108 related articles for article (PubMed ID: 2300900)
1. Local immunosuppression of the vascularized graft.
Gruber SA; Canafax DM; Cipolle RJ; Erdmann GR; Burke BA; Matas AJ; Simmons RL; Hrushesky WJ
Surgery; 1990 Feb; 107(2):209-14. PubMed ID: 2300900
[No Abstract] [Full Text] [Related]
2. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
Jones RM; Murie JA; Allen R; Jaskowski A; Morris PJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
[No Abstract] [Full Text] [Related]
3. Local immunosuppression of canine renal allografts with 15-deoxyspergualin.
Hughes SE; Xiao S; Perera S; Fluno C; Hasselbarth J; Jayasankar V; Singh J; Del Rosario A; Freed BM; Singh TP; Lempert N; Conti DJ; Gruber SA
Transplant Proc; 1996 Aug; 28(4):2054-5. PubMed ID: 8769153
[No Abstract] [Full Text] [Related]
4. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive effects of specific classes of agents with special reference to organ transplantation. Immunosuppression by thiopurines.
Zweiman B
Transplant Proc; 1973 Sep; 5(3):1197-201. PubMed ID: 4580719
[No Abstract] [Full Text] [Related]
6. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
Reissi D; Bardideh A; Samadzadeh B; Razi A
Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
[No Abstract] [Full Text] [Related]
7. Different immunosuppressive effects of liposomal FK506 in liver and kidney transplantation.
Ko S; Nakajima Y; Kanehiro H; Horikawa M; Yoshimura A; Kido K; Taki J; Aomatsu Y; Kin T; Yagura K; Ohyama T; Ohashi K; Yamada T; Nakano H
Transplant Proc; 1996 Apr; 28(2):1066-8. PubMed ID: 8623229
[TBL] [Abstract][Full Text] [Related]
8. WOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation.
Dresske B; Zavazava N; Jenisch S; Exner B; Lenz P; El Mokhtari NE; Kremer B; Faendrich F
Transplantation; 2003 Apr; 75(8):1286-91. PubMed ID: 12717217
[TBL] [Abstract][Full Text] [Related]
9. One-stage bilateral allotransplantation of canine lungs; further studies. Early rejection and prolonged survival with immunosuppression.
Kondo Y; Isin E; Cockrell JV; Hardy JD
J Thorac Cardiovasc Surg; 1972 Dec; 64(6):897-906. PubMed ID: 4564489
[No Abstract] [Full Text] [Related]
10. Pharmacodynamics of local heparin infusion in a canine renal allograft model.
Gruber SA; Cipolle RJ; Tzardis P; Skjei KL; Jossart G; Abed JF; Canafax DM; Burke BA; Matas AJ; Hrushesky WJ
J Pharmacol Exp Ther; 1990 Feb; 252(2):733-8. PubMed ID: 2313597
[TBL] [Abstract][Full Text] [Related]
11. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
[TBL] [Abstract][Full Text] [Related]
12. Some experimental and clinical studies of Cyclosporin A in renal transplantation.
Morris PJ
Transplant Proc; 1982 Sep; 14(3):525-8. PubMed ID: 6758238
[No Abstract] [Full Text] [Related]
13. Homotransplantation of limbs in rats. A preliminary report on an experimental study with nonspecific immunosuppressive drugs.
Doi K
Plast Reconstr Surg; 1979 Nov; 64(5):613-21. PubMed ID: 504483
[TBL] [Abstract][Full Text] [Related]
14. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
[TBL] [Abstract][Full Text] [Related]
15. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
16. Use of an immune function assay to monitor immunosuppression.
Grimm P
Pediatr Transplant; 2006 Aug; 10(5):533-5. PubMed ID: 16856988
[No Abstract] [Full Text] [Related]
17. Pretreatment of human renal allografts with monoclonal antibodies to induce long-term tolerance.
Taube D; Welsh KI; Bewick M; Dische FE; Palmer A; Parsons V; Snowden S
Transplant Proc; 1987 Feb; 19(1 Pt 3):1961-3. PubMed ID: 3274456
[No Abstract] [Full Text] [Related]
18. Prolongation of canine renal allograft survival by a new potent immunosuppressive agent, bactobolamine.
Kikuchi K; Tomikawa S; Ito S; Ichikawa N; Ando Y; Meigata K; Nomura Y; Watanabe K; Beck Y; Degawa H; Nagao T; Uchida H
Transplant Proc; 1996 Jun; 28(3):1392-3. PubMed ID: 8658709
[No Abstract] [Full Text] [Related]
19. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
[TBL] [Abstract][Full Text] [Related]
20. OKT3 rescue therapy for 63 refractory rejections in 405 renal allografts.
Uchida K; Namii Y; Tominaga Y; Haba T; Tanaka H; Ichimori T; Uemura O; Morozumi K; Hayashi S; Yokoyama J; Takagi H
Transplant Proc; 1996 Jun; 28(3):1358-9. PubMed ID: 8658693
[No Abstract] [Full Text] [Related]
[Next] [New Search]
